Jiasen He
Department of Pediatrics, Division of Pediatrics
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Patient Care, Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas
Education & Training
Degree-Granting Education
| 2017 | Shanghai Jiao Tong University School of Medicine, Shanghai, CN, Medicine, B. Med |
Postgraduate Training
| 2024-2025 | Postgraduate Fellow, Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2023-2024 | Chief Fellow, Hematology/Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texass |
| 2021-2024 | Fellow, Hematology/Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2018-2021 | Clinical Resident, University of Florida (Pensacola), Pensacola, Florida |
Licenses & Certifications
| 2025 | Medical |
| 2024 | Medical |
| 2021 | Board Certification |
Experience & Service
Extramural Institutional Committee Activities
Co-Chair, Brain Tumor Center Trainee Organizing Committee, The University of Texas MD Anderson Cancer Center, 2024 - Present
Member, GME Patient Safety Subcommittee, The University of Texas MD Anderson Cancer Center, 2022 - Present
Member, Pediatrics Education Team, The University of Texas MD Anderson Cancer Center, 2022 - Present
Honors & Awards
| 2024 - Present | Outstanding Achievement in Scholarly Activity, 2024 MD Anderson’s Children’s Cancer Hospital Fellowship Training Program |
| 2024 - Present | Best Oral Abstract Presentation, 2024 MD Anderson’s Children’s Cancer Hospital Fellowship Training Program |
| 2024 - Present | Outstanding Achievement in Hematology Research, 2024 MD Anderson’s Children’s Cancer Hospital Fellowship Training Program |
| 2023 - Present | American Society of Hematology Abstract Achievement Awards |
| 2023 - Present | Chinese American Hematologist and Oncologist Network Young Investigator Awards |
| 2023 - Present | Caroline Ross Endowment Fellowship in Brain Cancer Research |
| 2022 - Present | Outstanding Performance in Neuro-Oncology, 2022 MD Anderson’s Children’s Cancer Hospital Fellowship Training Program |
| 2022 - Present | Outstanding Performance in Non-Neural Solid Tumors, 2022 MD Anderson’s Children’s Cancer Hospital Fellowship Training Program |
| 2022 - Present | Outstanding Performance in Leukemia and Lymphoma, 2022 MD Anderson’s Children’s Cancer Hospital Fellowship Training Program |
| 2022 - Present | Outstanding (and awesome) Performance through Awesome Job Awards, 2022 MD Anderson’s Children’s Cancer Hospital Fellowship Training Program |
Grant & Contract Support
| Title: | Combining Virotherapy and Anti-GD2 CAR T cells for Diffuse Midline Glioma |
| Funding Source: | Chadtough Defeat DIPG Foundation |
| Role: | PI |
Selected Publications
Peer-Reviewed Articles
- He, J, Montanez, NA, Fraser, S, Barnett, A, Thennavan, A, Silos, C, Nkansah, F, Smith, K, Srivaths, LV. Characteristics and outcomes of pediatric cerebral venous sinus thrombosis: insights from the pediatric health information system database. Thrombosis Research, 2025. e-Pub 2025.
- He J. Managing and Preventing Hypofibrinogenemia in Pediatric and AYA Leukemia Patients: Insights From MD Anderson Cancer Center.". Journal of Pediatric Hematology/Oncology, 2025. e-Pub 2025.
- He J. "Immunotherapy-related neurotoxicity in the central nervous system of children with cancer.". Neuro-Oncology 27(5):625-643, 2025. e-Pub 2025.
- He J, Munir F, Catueno S, Connors JS, Gibson A, Robusto L, McCall D, Nunez C, Roth M, Tewari P. Biological Markers of High-Risk Childhood Acute Lymphoblastic Leukemia. Cancers 16(5):858, 2024. e-Pub 2024.
- Gibson, A, Dickson, S, McCall, D, Garcia, M, Connors, J, He, J, Roth, M, Nunez, C, Cuglievan, B, B. Venetoclax for pediatric patients with newly diagnosed acute myeloid leukemia. Pediatric blood & cancer, 2024. e-Pub 2024.
- Garcia-Moure, M, Laspidea, V, Gupta, S, Gillard, AG, Khatua, S, Parthasarathy, O, He, J, Lang, FF, Fueyo, J, Alonso, MM, Gomez-Manzano, C. The Emerging Field of Viroimmunotherapy for Pediatric Brain Tumors. Neuro-oncology, 2024. e-Pub 2024.
- Jiang H, Shin DH, Yi Y, Fan X, Gumin J, He J, Gillard AG, Lang FF, Gomez-Manzano C, Fueyo J. Adjuvant Therapy with Oncolytic Adenovirus Delta-24-RGDOX After Intratumoral Adoptive T-cell Therapy Promotes Antigen Spread to Sustain Systemic Antitumor Immunity. Cancer Res Commun 3(6):1118-1131, 2023. e-Pub 2023. PMID: 37379361.
- Trabal A, Gibson A, He J, McCall D, Roth M, Nunez C, Garcia M, Buzbee M, Toepfer L, Bidikian A, Daver N, Kadia T, Short NJ, Issa GC, Ravandi F, DiNardo CD, Montalban Bravo G, Garces S, Marcogliese A, Paek H, Dreyer Z, Brackett J, Redell M, Yi J, Garcia-Manero G, Konopleva M, Stevens A, Cuglievan B. Venetoclax for Acute Myeloid Leukemia in Pediatric Patients: A Texas Medical Center Experience. Cancers (Basel) 15(7), 2023. e-Pub 2023. PMID: 37046645.
- Cuglievan, Connors, He. Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies. Leu, 2023. e-Pub 2023.
- He J, Munir F, Ragoonanan D, Zaky W, Khazal SJ, Tewari P, Fueyo J, Gomez-Manzano C, Jiang H. Combining CAR T Cell Therapy and Oncolytic Virotherapy for Pediatric Solid Tumors: A Promising Option. Immuno 3(1):37-58, 2023. e-Pub 2023.
- He J, Garcia MB, Connors JS. Frontline Hyper-CVAD Plus Venetoclax for Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm. Journal of Pediatric Hematology/Oncology 45(8), 2023. e-Pub 2023.
Review Articles
- Munir F, Hardit V, Sheikh IN, AlQahtani S, He J, Cuglievan B, Hosing C, Tewari P, Khazal S. Classical Hodgkin Lymphoma: From Past to Future-A Comprehensive Review of Pathophysiology and Therapeutic Advances. Int J Mol Sci 24(12), 2023. e-Pub 2023. PMID: 37373245.
- Munir F, He J, Connors J, Garcia M, Gibson A, McCall D, Nunez C, Dinh CN, Robusto L, Roth M, Khazal S, Tewari P, Cuglievan B. Translational advances in the treatment of childhood acute lymphoblastic leukemia: narrative review of current and emerging molecular and immunotherapies. Transl Pediatr 12(3):487-502, 2023. e-Pub 2023. PMID: 37035397.
Patient Reviews
CV information above last modified January 15, 2026